VIR BIOTECHNOLOGIESLOGY INC
VIR BIOTECHNOLOGIESLOGY INC
Share · US92764N1028 · VIR (XNAS)
Overview Financial Indicators
5,47 USD
2,05 % 0,11 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
10.06.2025 22:44

Current Prices from VIR BIOTECHNOLOGIESLOGY INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
VIR
USD
10.06.2025 22:44
5,47 USD
5,43 USD
+0,74 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 2,53 % 7,57 % -23,07 % -32,39 % -51,20 % -84,25 %

Company Profile for VIR BIOTECHNOLOGIESLOGY INC Share

Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; collaboration with WuXi Biologics and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals SA. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Invested Funds

The following funds have invested in: VIR BIOTECHNOLOGIESLOGY INC invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
214,63
Percentage (%)
0,50 %

Company Data

Name VIR BIOTECHNOLOGIESLOGY INC
Company Vir Biotechnology, Inc.
Symbol VIR
Website https://www.vir.bio
Primary Exchange XNAS NASDAQ
ISIN US92764N1028
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.
Market Capitalization 745 Mio
Country United States of America
Currency USD
Employees 0,4 T
Address 499 Illinois Street, 94158 San Francisco
IPO Date 2019-10-11

Ticker Symbols

Name Symbol
NASDAQ VIR

More Shares

Investors who VIR BIOTECHNOLOGIESLOGY INC hold also have the following shares in their portfolio:
ALIGN TECHNOLOGIESLOGY INC
ALIGN TECHNOLOGIESLOGY INC Share
AMGEN INC
AMGEN INC Share
APPLE INC
APPLE INC Share
AUTODESK INC
AUTODESK INC Share
CADENCE DESIGN SYSTEMS INC
CADENCE DESIGN SYSTEMS INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
DZ BANK IS.A912 VAR
DZ BANK IS.A912 VAR Bond
ERSTE GR.BK. 21/28 MTN
ERSTE GR.BK. 21/28 MTN Bond
GARTNER INC
GARTNER INC Share
INTEL CORP
INTEL CORP Share
LGT-LGT SUS.EQ.EUROPE B
LGT-LGT SUS.EQ.EUROPE B Fund
MICROSOFT CORP
MICROSOFT CORP Share
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025